Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Labrie

Showing results (711-720 of 723) with videos related to

Pageof 73
Sort By:
Molecular and Cellular Endocrinology|October 1, 1974
Inhibition of growth hormone and thyrotropin release by growth hormone-release inhibiting hormoneA Belanger, F Labrie, P Borgeat, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2015
Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention ProgramK J Mather, C Kim, C A Christophi, et al.
Journal of Medicinal Chemistry|July 4, 1997
(S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogenS Gauthier, B Caron, J Cloutier, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2006
SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral densityA L Eriksson, M Lorentzon, D Mellström, et al.
Climacteric : the Journal of the International Menopause Society|December 17, 2014
Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophyC Bouchard, F Labrie, D F Archer, et al.
Climacteric : the Journal of the International Menopause Society|January 20, 2011
Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareuniaF Labrie, D F Archer, C Bouchard, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 1999
EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometriumF Labrie, C Labrie, A Bélanger, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
High risk genes predisposing to prostate cancer development-do they exist?R Singh, R A Eeles, F Durocher, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 17, 2009
Gonadal sex steroid status and bone health in middle-aged and elderly European menD Vanderschueren, S R Pye, K Venken, et al.
American Journal of Human Genetics|April 29, 1998
Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study CollaboratorsR A Eeles, F Durocher, S Edwards, et al.
Pageof 73

Showing results (711-720 of 723) with videos related to

Sort By:
Pageof 73
Molecular and Cellular Endocrinology|October 1, 1974
Inhibition of growth hormone and thyrotropin release by growth hormone-release inhibiting hormoneA Belanger, F Labrie, P Borgeat, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2015
Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention ProgramK J Mather, C Kim, C A Christophi, et al.
Journal of Medicinal Chemistry|July 4, 1997
(S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogenS Gauthier, B Caron, J Cloutier, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2006
SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral densityA L Eriksson, M Lorentzon, D Mellström, et al.
Climacteric : the Journal of the International Menopause Society|December 17, 2014
Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophyC Bouchard, F Labrie, D F Archer, et al.
Climacteric : the Journal of the International Menopause Society|January 20, 2011
Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareuniaF Labrie, D F Archer, C Bouchard, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 1999
EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometriumF Labrie, C Labrie, A Bélanger, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
High risk genes predisposing to prostate cancer development-do they exist?R Singh, R A Eeles, F Durocher, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 17, 2009
Gonadal sex steroid status and bone health in middle-aged and elderly European menD Vanderschueren, S R Pye, K Venken, et al.
American Journal of Human Genetics|April 29, 1998
Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study CollaboratorsR A Eeles, F Durocher, S Edwards, et al.
Pageof 73